Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Sun Pharma, CSIR-IICT ink licensing pact worth Rs 240 crore for patents

      Sun Pharma, CSIR-IICT ink licensing pact worth Rs 240 crore for patents

      Medical Dialogues Bureau17 Aug 2019 10:00 AM IST
      Sun Pharma will pay CSIR-IICT upfront and potential development, regulatory and sales milestone payments totalling up to Rs 240 crore plus royalties...
      Lupin gets USFDA nod for generic version of Prozac tablets to treat depressive disorder

      Lupin gets USFDA nod for generic version of Prozac tablets to treat depressive disorder

      Medical Dialogues Bureau17 Aug 2019 9:45 AM IST
      The company has received approval for Fluoxetine Tablets from the US Food and Drug Administration(USFDA) to market its product which is a generic...
      Roche personalized cancer treatment Rozlytrek priced at Rs 12 lakh per month

      Roche personalized cancer treatment Rozlytrek priced at Rs 12 lakh per month

      Medical Dialogues Bureau17 Aug 2019 9:15 AM IST
      Rozlytrek was approved by the U.S. Food and Drug Administration on Thursday to treat certain types of solid tumours, which show rare genetic anomalies...
      Morepen Labs Q1 export sale of Atorvastatin Calcium up by 57 percent

      Morepen Labs Q1 export sale of Atorvastatin Calcium up by 57 percent

      Medical Dialogues Bureau17 Aug 2019 9:13 AM IST
      Morepen Labs' export sales in Q1'FY 2019-20 for Montelukast Sodium rose by 210 per cent and that of Atorvastatin Calcium by 57 per cent vis-a-vis the...
      Celgene Inrebic gets USFDA nod for bone marrow cancer treatment

      Celgene Inrebic gets USFDA nod for bone marrow cancer treatment

      Medical Dialogues Bureau17 Aug 2019 9:00 AM IST
      Inrebic was approved based on results from a trial of 289 patients with myelofibrosis where the drug was tested against a placebo.U.S: The U.S. Food...
      Emcure Pharma gets USFDA Warning Letter for Manufacturing Violations at Pune plant

      Emcure Pharma gets USFDA Warning Letter for Manufacturing Violations at Pune plant

      Medical Dialogues Bureau16 Aug 2019 9:45 AM IST
      In the letter, the USFDA said inspectors during February 11-20 this year found significant deviations from standard manufacturing practices at Emcure...
      Sun Pharma records Total Revenue of Rs 8374.36 crore for June quarter

      Sun Pharma records Total Revenue of Rs 8374.36 crore for June quarter

      Medical Dialogues Bureau16 Aug 2019 9:30 AM IST
      Mumbai: India's largest drugmaker Sun Pharmaceutical Industries Ltd. (Sun Pharma) recently reported a consolidated net profit of Rs 1,387.48 crore...
      Serum Institute to unveil thermostable rotavirus vaccine Rotasiil in 9 countries next year

      Serum Institute to unveil thermostable rotavirus vaccine Rotasiil in 9 countries next year

      Medical Dialogues Bureau16 Aug 2019 9:26 AM IST
      Rotasiil remains stable for up to 30 months at a temperature of 25 degrees Celsius, Serum Institute said in a statement. This helps reduce vaccine...
      Novartis replaces top RnD executives at Avexis unit after test data manipulation

      Novartis replaces top RnD executives at Avexis unit after test data manipulation

      Medical Dialogues Bureau16 Aug 2019 9:25 AM IST
      Avexis' Chief Scientific Officer Brian Kaspar and Senior Vice President of Research and Development Allan Kaspar have not been involved in any...
      UK offers USD 30 million freight contract to maintain drug supply after Brexit

      UK offers USD 30 million freight contract to maintain drug supply after Brexit

      Medical Dialogues Bureau16 Aug 2019 9:00 AM IST
      LONDON: Britain is asking logistics providers to bid for a 25 million pound ($30 million) express freight contract to deliver medicines into the...
      Wish to see India excel in pharmaceutical research, says Delhi Deputy CM Manish Sisodia

      Wish to see India excel in pharmaceutical research, says Delhi Deputy CM Manish Sisodia

      Medical Dialogues Bureau15 Aug 2019 9:50 AM IST
      Addressing students of the Delhi Pharmaceutical Sciences and Research University (DPSRU), Pushp Vihar, here, Manish Sisodia said that India is placed...
      Syngene, Narayana Health, AIF launch CHAMPS- unique initiative to prevent, manage early onset of NCDs

      Syngene, Narayana Health, AIF launch CHAMPS- unique initiative to prevent, manage early onset of NCDs

      Medical Dialogues Bureau15 Aug 2019 9:30 AM IST
      The combined synergies of Narayana Health as a knowledge partner, Syngene and Biocon Foundation as funding partners and Agastya International as the...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok